Myasthenia gravis: Correlation of age with clinical course and anti-AChR antibody levels

International Journal of Immunopathology and Pharmacology

Volumn 12, Issue 3, 1999, Pages 127-131

  Kapinas, K ^a,b   Kimiskidis, V K ^a   Kazis, A D ^a   Kokkas, B ^a   Tsolaki, M ^a   Georgiadis, G ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b G Papanikolaou Hospital   (Greece)

Author keywords

Age; Anti AChR antibodies; Myasthenia gravis; Thymectomy

Indexed keywords

CHOLINERGIC RECEPTOR ANTIBODY; CHOLINESTERASE INHIBITOR;

ADOLESCENT; ADULT; AGE; AGED; ANTIBODY TITER; ARTICLE; DEATH; DISEASE COURSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MYASTHENIA GRAVIS; PRIORITY JOURNAL; PROGNOSIS;

EID: 0032748130     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Genkins G., P. Kornfeld, A. E. Papatestas, A. N. Bender and P. J. Maatta. 1987. Clinical experience in more than 2,000 patients with myasthenia gravis. Ann. NY. Acad. Sci. 505:500
2. Almon R. R., C. G Andrew and S. H Appel. 1974. Serum globulin in myasthenia gravis inhibition of α-bungarotoxin binding to acetylcholine receptors. Science 186:55
3. Vincent A. and J. Newsom-Davis. 1980. Anti-acetylcholine receptor antibodies. J. Neurol. Neurosurg. Psychiatry 43:590
4. Drachman D. B. 1994. Myasthenia gravis. N. Engl. J. Med. 330:1797
5. Heiser J. C., R. B. Rutherford and S. P. Ringel. 1982. Thymectomy for myasthenia gravis: a changing perspective. Arch. Surg. 117:533
6. Pascuzzi M. R., H. B. Coslett and R. T. Johns. 1984. Long term corticosteroid treatment of myasthenia gravis: Report of 116 patients. Ann. Neurol. 15:291
7. Grob D., N. G. Brunner and T. Namba. 1981. The natural course of myasthenia gravis and effect of therapeutic measures. Ann. NY. Acad. Sci. 377: 652
8. Oosterhuis H. J. G. H. 1989. The natural course of myasthenia gravis:a long term follow-up study. J. Neurol. Neurosurg. Psychiatry. 52:1121
9. Donaldson D. H., M. Ansher, S. Horan, R. B. Rutherford and S. P. Ringel. 1990. The relationship of age to outcome in myasthenia gravis. Neurology 40:786
10. Mantegazza R., E. Beghi, P. Pareyson, C. Antozzi, D. Pelluchetti, A. Sghirlanzoni, V. Cosi, M. Lombardi, G. Piccolo, P. Tonati, A. Evoli, E. Ricci, A. P. Battochi, C. Angelini, G. F. Micaglio, G. Marconi, R. Taiuti, L. Bergamini, L. Durelli and F. Cornelio. 1990. A multicentre follow-up study of 1152 patients with myasthenia gravis in Italy. J. Neurol. 237:339
11. Beekman R., J. B. M. Kuks and H. J. G. H. Oosterhuis. 1997. Myasthenia gravis:diagnosis and follow-up of 100 consecutive patients. J. Neurol. 244:112
12. Lindstrom J., B. Einarson and S. Tzartos. 1981. Production and assay of antibodies to Acetylcholine Receptors. Methods Enzymol. 74:432
13. Osserman K. E. and G. Genkins. 1966. Studies in myasthenia gravis. JAMA 198: 669
14. Oosterhuis H. J. G. H. 1988. Long term effects of treatment in 374 patients with myasthenia gravis. Monogr. Allergy. 25:75
15. Evoli A., A. P. Battochi, P. Tonali, M. T. Palmisani and M. Lino. 1996. Thymectomy for late-onset myasthenia gravis. Neurology 46:A310.
16. Rowland L. P. 1987. General discussion on therapy of myasthenia gravis. Ann. NY. Acad. Sci. 505:607
17. Olanow C. W., A. S. Wechsler, M. Sirotkin-Roses, J. Stajich and A. D. Roses. 1987. Thymectomy as primary therapy in myasthenia gravis. Ann. NY. Acad. Sci. 505: 595
18. Weksler M., R. Schwab and D. Al-Hao. 1996. Aging and the immune system. In Clinical Immunology:Principles and Practice. Rich RR, ed., Mosby Publications, St. Louis, Missuri p. 789.
19. Perlo V. P., B. Arnason and B. Castleman. 1975. The thymus gland in elderly patients with myasthenia gravis. Neurology 25:294
20. Newsom-Davis J., N. Willcox, M. Schluep, G. Harcourt, A. Vincent, S. Mossman, D. Wray and J. Burges. 1987. Immunological heterogeneity and cellular mechanisms in myasthenia gravis. Ann. NY. Acad. Sci. 505: 12